{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T08:57:08Z","timestamp":1773392228240,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":5191,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[1999,5]]},"DOI":"10.1006\/viro.1999.9695","type":"journal-article","created":{"date-parts":[[2002,10,7]],"date-time":"2002-10-07T14:46:43Z","timestamp":1034002003000},"page":"363-372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":146,"title":["Immunogenicity, Genetic Stability, and Protective Efficacy of a Recombinant, Chimeric Yellow Fever-Japanese Encephalitis Virus (ChimeriVax-JE) as a Live, Attenuated Vaccine Candidate against Japanese Encephalitis"],"prefix":"10.1006","volume":"257","author":[{"given":"F.","family":"Guirakhoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.-X.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.J.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Delagrave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.D.T.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.P.","family":"Monath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/viro.1999.9695_RF1","doi-asserted-by":"crossref","first-page":"8032","DOI":"10.1128\/JVI.72.10.8032-8036.1998","article-title":"Establishment and characterization of Japanese encephalitis virus-specific, human CD4+ T-cell clones: Flavivirus cross-reactivity, protein recognition, and cytotoxic activity","volume":"72","author":"Aihara","year":"1998","journal-title":"J. Virol."},{"key":"10.1006\/viro.1999.9695_RF2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00571925","article-title":"Identification of mutation that occurred on the genome of Japanese encephalitis virus during attenuation process","volume":"5","author":"Aihara","year":"1991","journal-title":"Virus Genes"},{"key":"10.1006\/viro.1999.9695_RF3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/biol.1997.0056","article-title":"Yellow fever vaccine","volume":"25","author":"Barrett","year":"1997","journal-title":"Biologicals"},{"key":"10.1006\/viro.1999.9695_RF4","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JVI.73.4.3095-3101.1999","article-title":"Yellow fever\/Japanese encephalitis chimeric viruses: Construction and biological properties","volume":"73","author":"Chambers","year":"1999","journal-title":"J. Virol."},{"key":"10.1006\/viro.1999.9695_RF5","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1128\/jvi.66.2.966-970.1992","article-title":"RNA sequence variants in live poliovirus vaccine and their relation to neurovirulence","volume":"66","author":"Chumakov","year":"1992","journal-title":"J. Virol."},{"key":"10.1006\/viro.1999.9695_RF6","first-page":"80","article-title":"A neurotropic variety of the vaccine strain 17D","volume":"11","author":"Collier","year":"1959","journal-title":"Trop. Geogr. Med."},{"key":"10.1006\/viro.1999.9695_RF7","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1099\/0022-1317-72-11-2811","article-title":"Recombinant baculovirus expressing yellow fever virus E and NS1 proteins elicit protective immunity in mice","volume":"72","author":"Despres","year":"1991","journal-title":"J Gen. Virol."},{"key":"10.1006\/viro.1999.9695_RF8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0168-1702(94)00076-O","article-title":"Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213","volume":"35","author":"Duarte dos Santos","year":"1995","journal-title":"Virus Res."},{"key":"10.1006\/viro.1999.9695_RF9","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1093\/nar\/17.10.3989","article-title":"Nucleotide sequence comparison of the genome of two 17D-204 yellow fever vaccines","volume":"17","author":"Dupuy","year":"1989","journal-title":"Nucleic Acids Res."},{"key":"10.1006\/viro.1999.9695_RF10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/0022-1317-46-1-1","article-title":"The in vivo differentiation of strains of yellow fever virus in mice","volume":"46","author":"Fitzgeorge","year":"1980","journal-title":"J. Gen. Virol."},{"key":"10.1006\/viro.1999.9695_RF11","doi-asserted-by":"crossref","first-page":"679","DOI":"10.4269\/ajtmh.1984.33.679","article-title":"Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. IV. Characterization of a vaccine candidate in fetal rhesus lung cells","volume":"33","author":"Halstead","year":"1984","journal-title":"Am. Soc. Trop. Med. Hyg."},{"key":"10.1006\/viro.1999.9695_RF12","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0140-6736(96)91075-2","article-title":"Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14\u201314-2): A case-control study","volume":"347","author":"Hennessy","year":"1996","journal-title":"Lancet"},{"key":"10.1006\/viro.1999.9695_RF13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1056\/NEJM198809083191004","article-title":"Protection against Japanese encephalitis by inactivated vaccines","volume":"319","author":"Hoke","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/viro.1999.9695_RF14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0264-410X(96)00180-6","article-title":"Particulate vaccine candidate for Japanese encephalitis induces long-lasting memory T lymphocytes in mice","volume":"15","author":"Konishi","year":"1997","journal-title":"Vaccine"},{"key":"10.1006\/viro.1999.9695_RF15","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1128\/JVI.72.6.4925-4930.1998","article-title":"Induction of protective immunity against Japanese encephalitis with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes","volume":"72","author":"Konishi","year":"1998","journal-title":"J. Virol."},{"key":"10.1006\/viro.1999.9695_RF16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/viro.1994.1335","article-title":"The flavivirus nonstructural protein NS3 is a dominant source of cytotoxic T cell peptide determinants","volume":"202","author":"Lobigs","year":"1994","journal-title":"Virlogy"},{"key":"10.1006\/viro.1999.9695_RF17","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1099\/0022-1317-69-7-1637","article-title":"Interferon induction by viruses. XVI. 2-Aminopurine block selectively and reversibly an early stage in interferon induction","volume":"69","author":"Marcus","year":"1988","journal-title":"J. Gen. Virol."},{"key":"10.1006\/viro.1999.9695_RF18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0042-6822(87)90207-8","article-title":"Partial nucleotide sequence of Japanese encephalitis virus genome","volume":"158","author":"McAda","year":"1987","journal-title":"Virology"},{"key":"10.1006\/viro.1999.9695_RF19","unstructured":"Monath, T. P. 1999, Yellow fever, In, Vaccines, W.B. Saunders, Phila, PA"},{"key":"10.1006\/viro.1999.9695_RF20","series-title":"Fields Virology","first-page":"961","article-title":"Flaviviruses","author":"Monath","year":"1996"},{"key":"10.1006\/viro.1999.9695_RF21","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0264-410X(98)00487-3","article-title":"Recombinant, chimeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14\u201314-2) and the capsid and nonstructural genes of yellow fever (17D) is safe, immunogenic and protective in non-human primates","volume":"17","author":"Monath","year":"1999","journal-title":"Vaccine"},{"key":"10.1006\/viro.1999.9695_RF22","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1099\/0022-1317-75-6-1505","article-title":"Comparison of nucleotide and deduced amino acid sequence of the 5 non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives","volume":"75","author":"Ni","year":"1994","journal-title":"J. Gen. Virol."},{"key":"10.1006\/viro.1999.9695_RF23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1099\/0022-1317-76-2-409","article-title":"Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14","volume":"76","author":"Ni","year":"1995","journal-title":"J. Gen. Virol."},{"key":"10.1006\/viro.1999.9695_RF24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0042-6822(90)90519-W","article-title":"Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivatives, SA14\u201314-2","volume":"177","author":"Nitayaphan","year":"1990","journal-title":"Virology"},{"key":"10.1006\/viro.1999.9695_RF25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0042-6822(92)90745-B","article-title":"Heterogeneity in envelope protein sequence and N-linked glycosylation among yellow fever virus vaccine strains","volume":"188","author":"Post","year":"1992","journal-title":"Virology"},{"key":"10.1006\/viro.1999.9695_RF26","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1099\/0022-1317-71-8-1697","article-title":"Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b","volume":"71","author":"Putnak","year":"1990","journal-title":"J. Gen. Virol."},{"key":"10.1006\/viro.1999.9695_RF27","first-page":"285","article-title":"Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation","volume":"1","author":"Rice","year":"1989","journal-title":"New Biol."},{"key":"10.1006\/viro.1999.9695_RF28","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.4023707","article-title":"Nucleotide sequence of yellow fever virus: Implication for flavivirus gene expression and evolution","volume":"229","author":"Rice","year":"1985","journal-title":"Science"},{"key":"10.1006\/viro.1999.9695_RF29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/viro.1993.1015","article-title":"The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against yellow fever encephalitis in mice","volume":"192","author":"Schlesinger","year":"1993","journal-title":"Virology"},{"key":"10.1006\/viro.1999.9695_RF30","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1089\/jir.1985.5.651","article-title":"Interferon induction by viruses. XIV. Development of interferon inducibility and its inhibition in chick embryo cells \u201caged\u201din vitro","volume":"5","author":"Sekellick","year":"1985","journal-title":"J. Interferon Res."},{"key":"10.1006\/viro.1999.9695_RF31","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/infdis\/171.5.1144","article-title":"Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA","volume":"171","author":"Sumiyoshi","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1006\/viro.1999.9695_RF32","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.65.6.787","article-title":"The use of yellow fever virus modified byin vitro","volume":"65","author":"Theiler","year":"1937","journal-title":"J. Exp. Med."},{"key":"10.1006\/viro.1999.9695_RF33","first-page":"337","volume":"73","year":"1998","journal-title":"Weekly Epidemiological Record. No. 44"},{"key":"10.1006\/viro.1999.9695_RF34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0168-1702(98)00036-7","article-title":"Yellow fever 17D vaccine virus isolated from healthy vaccinees accumulates very few mutations","volume":"55","author":"Xie","year":"1998","journal-title":"Virus Res."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682299996952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682299996952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T22:58:31Z","timestamp":1758581911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682299996952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["S0042682299996952"],"URL":"https:\/\/doi.org\/10.1006\/viro.1999.9695","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[1999,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity, Genetic Stability, and Protective Efficacy of a Recombinant, Chimeric Yellow Fever-Japanese Encephalitis Virus (ChimeriVax-JE) as a Live, Attenuated Vaccine Candidate against Japanese Encephalitis","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/viro.1999.9695","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1999 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}